SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lansang, M C.
Right arrow Articles by Hollenberg, N. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lansang, M C.
Right arrow Articles by Hollenberg, N. K
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Hyperglycaemia-induced intrarenal RAS activation: the contribution of metabolic pathways

M Cecilia Lansang

Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA, mlansang@ partners.org

Suzette Y Osei

Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA

Caroline Coletti

Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA

Janelle Krupinski

Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA

Norman K Hollenberg

Departments of Medicine and Radiology, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA

Hyperglycaemia-induced activation of the renin-angiotensin system (RAS) has been observed in normal and diabetic humans. Our main objective was to determine whether the mechanism involved a physical or metabolic effect of glucose. First, Sprague-Dawley rats of the CD strain were given sequential intravenous (i.v.) doses of 0.01, 0.1, 1.0, and 3.0 mg/kg candesartan 30 minutes apart, in the presence of a continuous i.v. infusion of dextrose 20% in water (D20W). The 0.1 mg/kg dose produced a maximal renal blood flow (RBF) response and was used thereafter. Another set of animals then received an infusion of either normal saline (NS), dextrose 5% in water (D5W) or dextrose 20% in water (D20W) for 2 hours, followed by candesartan 0.1 mg/kg i.v. Finally, the response to candesartan 0.1 mg/kg i.v. during D20W infusion was compared with that during infusion of 2-deoxyglucose (2DG), a glucose analogue that competitively inhibits the glycolytic enzyme, hexokinase. RBF (electromagnetic flowmeter), blood pressure (BP), blood glucose, and urine glucose were monitored. There was no significant RBF response to candesartan on either NS (6.01±0.48 to 6.20±0.49 ml/minute/g kidney; p=0.216) or D5W (7.63±1.20 to 7.58±1.39 ml/minute/g kidney; p=0.965), whereas there was a significant response to D20W (6.64±0.59 to 7.46±0.67 ml/minute/g kidney; p=0.002). The RBF response was significantly enhanced by D20W compared with 2DG (change in RBF: 0.82±0.22 vs. -0.04±0.26; p=0.05), despite similar BP, blood glucose, and urine glucose. Glucose acts, at least in part, through intracellular utilisation to induce RAS activation, as manifested by an enhanced renal vascular response to an angiotensin II antagonist.

Key Words: candesartan • 2-deoxyglucose • glucose

Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 1, 19-23 (2002)
DOI: 10.3317/jraas.2002.003


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
D. Z.I. Cherney, V. Lai, J. W. Scholey, J. A. Miller, B. Zinman, and H. N. Reich
Effect of Direct Renin Inhibition on Renal Hemodynamic Function, Arterial Stiffness, and Endothelial Function in Humans With Uncomplicated Type 1 Diabetes: A pilot study
Diabetes Care, February 1, 2010; 33(2): 361 - 365.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J.-H. Oak and H. Cai
Attenuation of Angiotensin II Signaling Recouples eNOS and Inhibits Nonendothelial NOX Activity in Diabetic Mice
Diabetes, January 1, 2007; 56(1): 118 - 126.
[Abstract] [Full Text] [PDF]



Advertisement